KALA BIO, Inc. (KALA)
NASDAQ·Healthcare·Biotechnology
$0.77
-1.42%
Mkt Cap $5.69M
Analyst Ratings
No recent rating data.
Price Target (5 analysts)
$18.25
Range $1.50 – $35.00
Implied Upside
+2264.3%
Consensus $18.25 vs current $0.77
NASDAQ·Healthcare·Biotechnology
$0.77
-1.42%
Mkt Cap $5.69M
No recent rating data.
Price Target (5 analysts)
$18.25
Range $1.50 – $35.00
+2264.3%
Consensus $18.25 vs current $0.77